skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Please share your analysis of the recent results. Looks like most of the growth is driven by Handicare and very little or no organic growth. Please share your comments in organic vs. inorganic growth.
What are the future prospects after acquisition
Will dividends be maintained and what about dividend growth.
Will Savara be able to generate decent cash flow or will they have to resort to debt to manage new acquisition and future plans?
Read Answer Asked by Sridhar on May 20, 2021
Q: Would holding GUD be close to the equivalent of holding cash right now? I understand it’s a security and nothing is 100% safe but when I look at the cash in hand along with Goodman’s shares (which I assume he’s in no rush to sell) it’s probably around the current price per share. Would you see this as a viable alternative to a piece of the cash portion of a portfolio with nice potential upside long term? Thanks as always for this service!
Read Answer Asked by Peter on May 19, 2021
Q: I am concerned regarding Mr Vounassis background at Bombardier. Given that Bombardier has been the worst performing stock in history and an ultimate example of corporate welfare, it is not a good name to have on a resume.
Also, sometimes applying methodology from large corporations to smaller companies does not work so well.
I hold some XBC and will continue holding but I have concerns.
Your comments please
Thanks for your great service
Read Answer Asked by Clarence on May 19, 2021
Q: You recently commented that at this point you like TFII better than CNR and CPR. Could you elaborate and would you consider TFII a good choice for growth if we have inflationary pressures.
Thanks!
Read Answer Asked by Greg on May 19, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!